Search research articles
Contact Us
Filters
Showing results (81-90 of 497) with videos related to
Page
of 50
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
September 21, 2018
Management of Biochemically Recurrent Prostate Cancer: Ensuring the Right Treatment of the Right Patient at the Right Time
Daniel E Spratt, Deaglan J McHugh, Michael J Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2020
Reply to L. C. Mendez et al and M. A. Kollmeier et al
William C Jackson, Holly E Hartman, Robert T Dess, et al.
Nature Reviews. Clinical Oncology
|
June 2, 2016
Translational and clinical implications of the genetic landscape of prostate cancer
Daniel E Spratt, Zachary S Zumsteg, Felix Y Feng, et al.
The Lancet. Oncology
|
June 15, 2016
Vessel-sparing radiation and functional anatomy-based preservation for erectile function after prostate radiotherapy
Jae Y Lee, Daniel E Spratt, Adam L Liss, et al.
NPJ Breast Cancer
|
October 16, 2020
ARe we there yet? Understanding androgen receptor signaling in breast cancer
Anna R Michmerhuizen, Daniel E Spratt, Lori J Pierce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2019
Reply to J.R. Rider et al
Payal D Soni, Holly E Hartman, Matthew J Schipper, et al.
American Journal of Clinical Oncology
|
October 10, 2023
Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients: Incidence and Success Rate of Peer-To-Peer Authorization in Allowing Patients to Remain Trial-Eligible
Shearwood McClelland, Melissa Brately, Raed J Zuhour, et al.
Future Oncology (London, England)
|
March 7, 2025
The impact of concomitant therapies on the efficacy and safety of relugolix in advanced prostate cancer
Neal D Shore, Daniel J George, Daniel E Spratt, et al.
Biometrical Journal. Biometrische Zeitschrift
|
May 17, 2017
Comparison of joint modeling and landmarking for dynamic prediction under an illness-death model
Krithika Suresh, Jeremy M G Taylor, Daniel E Spratt, et al.
Journal of the National Cancer Institute
|
November 14, 2024
Response to Semprini and Osazuwa-Peters
Kyle A Mani, Xue Wu, Daniel E Spratt, et al.
Page
of 50
Search research articles
Search
Showing results (81-90 of 497) with videos related to
Sort By:
Page
of 50
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
September 21, 2018
Management of Biochemically Recurrent Prostate Cancer: Ensuring the Right Treatment of the Right Patient at the Right Time
Daniel E Spratt, Deaglan J McHugh, Michael J Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2020
Reply to L. C. Mendez et al and M. A. Kollmeier et al
William C Jackson, Holly E Hartman, Robert T Dess, et al.
Nature Reviews. Clinical Oncology
|
June 2, 2016
Translational and clinical implications of the genetic landscape of prostate cancer
Daniel E Spratt, Zachary S Zumsteg, Felix Y Feng, et al.
The Lancet. Oncology
|
June 15, 2016
Vessel-sparing radiation and functional anatomy-based preservation for erectile function after prostate radiotherapy
Jae Y Lee, Daniel E Spratt, Adam L Liss, et al.
NPJ Breast Cancer
|
October 16, 2020
ARe we there yet? Understanding androgen receptor signaling in breast cancer
Anna R Michmerhuizen, Daniel E Spratt, Lori J Pierce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2019
Reply to J.R. Rider et al
Payal D Soni, Holly E Hartman, Matthew J Schipper, et al.
American Journal of Clinical Oncology
|
October 10, 2023
Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients: Incidence and Success Rate of Peer-To-Peer Authorization in Allowing Patients to Remain Trial-Eligible
Shearwood McClelland, Melissa Brately, Raed J Zuhour, et al.
Future Oncology (London, England)
|
March 7, 2025
The impact of concomitant therapies on the efficacy and safety of relugolix in advanced prostate cancer
Neal D Shore, Daniel J George, Daniel E Spratt, et al.
Biometrical Journal. Biometrische Zeitschrift
|
May 17, 2017
Comparison of joint modeling and landmarking for dynamic prediction under an illness-death model
Krithika Suresh, Jeremy M G Taylor, Daniel E Spratt, et al.
Journal of the National Cancer Institute
|
November 14, 2024
Response to Semprini and Osazuwa-Peters
Kyle A Mani, Xue Wu, Daniel E Spratt, et al.
Page
of 50